NE3107 in Adults With Neurological Symptoms of Long COVID
NCT06847191 · Long COVID
Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in people with Long COVID including difficulty concentrating or remembering things ("brain fog") and fatigue. Researchers will compare NE3107 to a placebo (a look-alike substance that contains no drug) to see if NE3107 works to treat neurocognitive and fatigue symptoms of long COVID. Participants will: * Take NE3107 or a placebo twice daily for 84 days * Visit the clinic 5 times for checkups and tests and have a follow up phone call
PhasePhase 2
TypeInterventional
Age18 Years – 69 Years
WherePalo Alto, California, United States + 19 more
SponsorBioVie Inc.
▾Tap for detailsClick for full details — eligibility, all locations, contacts
20 sitesApply